May 2022

More United: Collaboration in the Time of Covid: a QBI/Gladstone Symposium with John Bridgeland

Monday, June 6, 2022 - 11:00 am to 12:00 pm

The QBI & Gladstone Institute Infectious Disease and Human Health Seminar Series presents John Bridgeland, Founder & CEO of Civic, a social enterprise firm in Washington, D.C. He is also Executive Chairman of the Office of American Possibilities, a moonshot factory to tap the entrepreneurial talent of Americans to solve public challenges together across divides.

Not everything in life is sh#$%: how enteric viruses transmit

Monday, May 23, 2022 - 11:00 am to 12:00 pm

The QBI & Gladstone Institute Infectious Disease and Human Health Seminar Series presents Dr. Nihal Altan-Bonnet, Head of the Laboratory of Host-Pathogen Dynamics at the National Heart Lung and Blood Institute of the National Institutes of Health in Bethesda, Maryland, USA.

UCSF QBI Coronavirus Research Group awarded $67.5 million to develop therapies for future pandemics

Award is the largest NIH grant in UCSF history

Update from the Dean: Passing the torch

Interim Dean Thomas Kearney provides the latest on the School’s activities and announces the selection of the next dean, Kathy Giacomini, PhD

2-deoxy-D-glucose exploits increased glucose metabolism in cancer and viral-infected cells: relevance to its use in India against SARS-CoV-2

Wednesday, May 18, 2022 - 11:00 am to 12:00 pm

The QBI Seminar Series is presenting Theodore Lampidis, a professor in the Department of Cell Biology at the Miller School of Medicine, and the Sylvester Comprehensive Cancer Center at the University of Miami. Dr. Lampidis graduated from Brooklyn College with a BS in chemistry, received a master’s degree from NYU in Medical Microbiology and his Ph.D. from the University of Miami in Immunology & Microbiology.

David vs Goliath: Ribosome-targeting antibiotics and bacterial resistance mechanisms

Tuesday, May 10, 2022 - 11:00 am to 12:00 pm

The QBI Seminar Series is presenting Daniel Wilson, a professor of Biochemistry at the Institute for Biochemistry and Molecular Biology, University of Hamburg, Germany. Wilson group uses a combination of structural and molecular biology tools to provide insight into the fundamental process of protein synthesis as well as providing a mechanistic basis upon which to develop new and improved antimicrobial agents.

Giacomini named dean of UCSF School of Pharmacy

Renowned pharmaceutical scientist brings decades of experience at the intersection of research, patient care, and education to lead the School

Shondell Moody

Chief Administrative Officer